BG105236A - Нови производни на карбоксилни киселини със странични кетовериги, тяхното получаване и използванетоим като антагонисти на ендотелинови рецептори - Google Patents

Нови производни на карбоксилни киселини със странични кетовериги, тяхното получаване и използванетоим като антагонисти на ендотелинови рецептори

Info

Publication number
BG105236A
BG105236A BG105236A BG10523601A BG105236A BG 105236 A BG105236 A BG 105236A BG 105236 A BG105236 A BG 105236A BG 10523601 A BG10523601 A BG 10523601A BG 105236 A BG105236 A BG 105236A
Authority
BG
Bulgaria
Prior art keywords
endothelin
production
carboxylic acid
acid derivatives
receptor antagonists
Prior art date
Application number
BG105236A
Other languages
English (en)
Inventor
Wilhelm Amberg
Rolf Jansen
Georg Kettschau
Stefan Hergenroeder
Manfred Raschack
Liliane Unger
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG105236A publication Critical patent/BG105236A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Изобретението се отнася до производни на карбоксилни киселини с формула, в която заместителите иматпосочените в описанието значения, до получаванетои използването им като антагонисти на ендотелинови рецептори.
BG105236A 1998-08-10 2001-02-09 Нови производни на карбоксилни киселини със странични кетовериги, тяхното получаване и използванетоим като антагонисти на ендотелинови рецептори BG105236A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19836044A DE19836044A1 (de) 1998-08-10 1998-08-10 Neue Carbonsäurederivate, die Ketoseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten
PCT/EP1999/005728 WO2000009489A1 (de) 1998-08-10 1999-08-07 Neue carbonsäurederivate, die ketoseitenketten tragen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten

Publications (1)

Publication Number Publication Date
BG105236A true BG105236A (bg) 2001-12-29

Family

ID=7876981

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105236A BG105236A (bg) 1998-08-10 2001-02-09 Нови производни на карбоксилни киселини със странични кетовериги, тяхното получаване и използванетоим като антагонисти на ендотелинови рецептори

Country Status (22)

Country Link
EP (1) EP1104410A1 (bg)
JP (1) JP2002522531A (bg)
KR (1) KR20010072378A (bg)
CN (1) CN1323298A (bg)
AR (1) AR020147A1 (bg)
AU (1) AU5374199A (bg)
BG (1) BG105236A (bg)
BR (1) BR9912889A (bg)
CA (1) CA2340167A1 (bg)
CO (1) CO5261504A1 (bg)
DE (1) DE19836044A1 (bg)
HK (1) HK1042086A1 (bg)
HR (1) HRP20010164A2 (bg)
HU (1) HUP0104007A3 (bg)
ID (1) ID27965A (bg)
IL (1) IL140915A0 (bg)
NO (1) NO20010622D0 (bg)
PL (1) PL345998A1 (bg)
SK (1) SK832001A3 (bg)
TR (1) TR200100427T2 (bg)
WO (1) WO2000009489A1 (bg)
ZA (1) ZA200101975B (bg)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (de) * 1999-06-01 2000-12-07 Basf Ag Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (de) * 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten

Also Published As

Publication number Publication date
ZA200101975B (en) 2002-03-11
HUP0104007A2 (hu) 2002-05-29
ID27965A (id) 2001-05-03
CO5261504A1 (es) 2003-03-31
SK832001A3 (en) 2001-11-06
TR200100427T2 (tr) 2001-07-23
JP2002522531A (ja) 2002-07-23
PL345998A1 (en) 2002-01-14
DE19836044A1 (de) 2000-02-17
NO20010622L (no) 2001-02-06
EP1104410A1 (de) 2001-06-06
HRP20010164A2 (en) 2002-04-30
AU5374199A (en) 2000-03-06
CN1323298A (zh) 2001-11-21
CA2340167A1 (en) 2000-02-24
HK1042086A1 (zh) 2002-08-02
IL140915A0 (en) 2002-02-10
HUP0104007A3 (en) 2002-12-28
AR020147A1 (es) 2002-04-10
NO20010622D0 (no) 2001-02-06
WO2000009489A1 (de) 2000-02-24
KR20010072378A (ko) 2001-07-31
BR9912889A (pt) 2001-05-08

Similar Documents

Publication Publication Date Title
BG103413A (bg) Производни на сулфиновата киселина, тяхното получаване и използване
BG104831A (bg) Заместени с хетероцикли амиди, получаването им и използването им
BG106444A (bg) Производни на бензодиазепин, тяхното получаване иизползването им
RS86804A (en) Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents
RS20050616A (en) Pyrazoles and methods of making and using the same
RS20050199A (en) Imidazolopyridines and methods of making and using the same
PL367094A1 (en) Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
CA2333008A1 (en) New heterocyclically substituted amides, their production and their use
BG108426A (bg) Нови производни на сулфоновата киселина
ZA9410181B (en) Arylacetic acid derivatives.
BG104396A (bg) Нови производни на карбоксилни киселини с амидна странична верига, тяхното получаване и използването им като ендотелин-рецепторни антагонисти
BG104291A (bg) 3-заместени тетрахидропиридопиримидинонови производни, тяхното получаване и използване
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BG104022A (bg) Нови производни на бета-амино- и бета-азидокарбоксилна киселина, тяхното получаване и използването им като антагонисти на ендотелинов рецептор
TR200000371T2 (tr) 3-İkame edilen 3,4,5,7,- tetrahidro-pirrolo [3',4':4,5] tieno[2,3-D] pirimidin türevleri, üretimi ve 5HT-antagonistleri olarak kullanımları.
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
BG105236A (bg) Нови производни на карбоксилни киселини със странични кетовериги, тяхното получаване и използванетоим като антагонисти на ендотелинови рецептори
BG104222A (bg) НОВИ ПРОИЗВОДНИ НА КАРБОНОВИ КИСЕЛИНИ, ТЯХНОТО ПОЛУЧАВАНЕ И ИЗПОЛЗВАНЕТО ИМ КАТО СМЕСЕНИ ЕТa/ЕТb РЕЦЕПТОРНИ АНТАГОНИСТИ
BG105618A (bg) -амидо и -сулфонамидни производни на карбоксилни киселини, метод за тяхното получаване и приложението им като ендотелин-рецепторни антагонисти
BG105326A (bg) Нови бензоилгуанидинови производни с преимуществени свойства, метод за тяхното получаване и тяхнотоприложение при производството на лекарствени средства
BG106154A (bg) Производни на карбоксилна киселина с арил заместени, съдържащи азот хетероцикли, метод за получаването им и използването им като антагонисти на ендотелинови рецептори
MXPA04001977A (es) Antagonistas v de receptor ccr-3.
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
BG106321A (bg) Нови производни на карбоксилната киселина с 5,6-заместено пиримидиново ядро, тяхното получаване и използването им като антагонисти на ендотелиновия рецептор
IL137038A0 (en) 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists